66% of patients with scalp psoriasis and 77% with genital psoriasis treated with investigational icotrokinra achieved site-specific clear or almost clear skin at Week 16 Icotrokinra continues to demonstrate a standout combination of significant skin clearance (IGA 0/1) and a favorable safety profile in …
Data from icotrokinra ICONIC-TOTAL show 66% of patients with scalp psoriasis and 77% with genital psoriasis achieved site-specific clear or almost clear skin at Week 16 Icotrokinra continues to demonstrate a standout combination of significant skin clearance (IGA 0/1) and a favorable safety profile …
Tutor Perini (NYSE:TPC) First Quarter 2025 Results Key Financial Results Revenue: US$1.25b (up 19% from 1Q 2024). Net income: US$28.0m (up 78% from 1Q 2024). Profit margin: 2.2% (up from 1.5% in 1Q 2024). The increase in margin was driven by higher revenue. EPS: …
We recently published a list of Billionaire Rob Citrone’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Vista Energy, S.A.B. de C.V. (NYSE:VIST) stands against Billionaire Rob Citrone’s other small-cap stock picks …
Stocks jumped Thursday on a Trump trade deal with the U.K., but pared gains on a report that Trump wants to hike taxes on the wealthy. Robinhood led new buys. Continue Reading View Comments
We recently published a list of Billionaire Rob Citrone’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Grupo Financiero Galicia S.A. (NASDAQ:GGAL) stands against Billionaire Rob Citrone’s other small-cap stock picks with …
Marqeta (NASDAQ:MQ) First Quarter 2025 Results Key Financial Results Revenue: US$139.1m (up 18% from 1Q 2024). Net loss: US$8.26m (loss narrowed by 77% from 1Q 2024). US$0.016 loss per share (improved from US$0.07 loss in 1Q 2024). Our free stock report includes 1 warning …
LPL Financial’s LPLA first-quarter 2025 adjusted earnings of $5.15 per share handily outpaced the Zacks Consensus Estimate of $4.54. The bottom line also grew 22% year over year. Results benefited from robust revenue improvement, partly offset by higher expenses. LPLA recorded growth in brokerage …
Veeco Instruments (NASDAQ:VECO) First Quarter 2025 Results Key Financial Results Revenue: US$167.3m (down 4.1% from 1Q 2024). Net income: US$11.9m (down 45% from 1Q 2024). Profit margin: 7.1% (down from 13% in 1Q 2024). The decrease in margin was primarily driven by lower revenue. …
The buy now, pay later giant says it can navigate any periods of uncertainty. J.P. Morgan trims estimates anyway. Continue Reading View Comments